Pharma R&D

Collaborative effort between biotech companies, PDC*line Pharma and OncoDNA, technology company salamanderU and universities…

Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre (VMRC) also states…

CPHI and PMEC India expo attracted over 48,000 attendees from 120+ countries and over 1,500 exhibitors

Prof Arun Kumar Shukla, Professor and Sonu Agrawal Memorial Chair, Biological Sciences and Bioengineering, Indian Institute of…

Eugene Polini, Technical Key Account Manager at Datwyler points out that injectable therapies are some of the most highly…

Revenues of ICRA’s sample set expected to grow by 6-8 per cent in FY2023 and FY2024; operating profit margins to stabilise at…

Dr Reed will join J&J on April 3, 2023, assuming responsibility for the company’s portfolio from Dr William Hait, who has…

Dr Sanjay Kumar Jain, President - India Operations, Amneal Pharmaceuticals speaks about the emerging trends in pharma R&D,…

As policymakers strive to link budgetary allocations to better quality compliance, with stricter oversight?

A policy to incentivise pharma R&D is crucial as there are already signs that pharma R&D dives when revenues dip